The polycomb group protein enhancer of zeste homolog 2 (EZH2) regulating cell cycle and functioning
as a transcriptional repressor, is overexpressed in several human cancers. Therefore it can be a
molecular marker for detection of cancer progression and metastasis. Here the
electrochemiluminescence (ECL) assay was developed to detect and quantify the amount of EZH2
mRNA expression in cancer cell. Total mRNA was reverse transcribed into cDNA. The cDNA was
amplified using a forward and reverse primer pair which were labeled with biotin and Tris (2,
2-bipyridine) ruthenium (II) (TBR) on the 5' end, respectively. The amplification product was captured
on streptavidin coated magnetic beads and then separated using a magnetic field. The TBR labels were
reacted with the most efficient coreactant, TPA, on the electrode. Photons were produced and detected
by a custom-built ECL system. The housekeeping gene hydroxymethylbilane synthase (HMBS) was
used as an approximate reference to quantify the amount of EZH2 mRNA expression, whose primer
pairs were labeled the same as EZH2. Result indicated that the EZH2 mRNA was overexpressed in
MCF-7 cells relative to normal blood cells. This assay is specific and sensitive and could be used for
the clinical diagnosis and prognosis of cancer.
|